Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Regulation of biomarker analysis: what can be translated in the clinic?

6 Aug 2025

Abstract excerpt

INTRODUCTION: The introduction of biomarkers in precision medicine is heralding a new era of diagnostic power and personalized patient care. Biomarkers are critical tools for detecting various diseases, guiding treatment decisions, and predicting patient responses, thereby improving outcomes and reducing healthcare costs. AREAS COVERED: This review examines the regulatory landscape governing biomarker development...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Radiomics and Machine Learning in Medical Imaging
Share to Statistical Methods in Clinical Trials

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 40765252
DOI: 10.1080/14737159.2025.2534962

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Regulation of biomarker analysis: what can be translated in the clinic?PMID 40765252Read ↗

From Discovery to Implementation: Bringing Proteomics to the ClinicSemantic proximity Read ↗

Delivery of High‐Quality Biomarker AssaysSemantic proximity Read ↗

Improving the power of diagnostics in the era of targeted therapy and personalized healthcare.Semantic proximity Read ↗

AI-driven biomarker discovery: enhancing precision in cancer diagnosis and prognosisSemantic proximity Read ↗

In Pursuit of Greater Reproducibility and Credibility of Early Clinical Biomarker ResearchSemantic proximity Read ↗

The interface between biomarker discovery and clinical validation: The tar pit of the protein biomarker pipeline.Semantic proximity Read ↗

A State-of-the-Art Roadmap for Biomarker-Driven Drug Development in the Era of Personalized TherapiesSemantic proximity Read ↗

Inconvenient truth: Cancer biomarker development by using proteomicsSemantic proximity Read ↗

Biomarker Tests Need Closer Scrutiny, IOM ConcludesSemantic proximity Read ↗

Cancer Biomarker Discovery for Precision Medicine: New ProgressSemantic proximity Read ↗

Foresight in clinical proteomics: current status, ethical considerations, and future perspectivesSemantic proximity Read ↗

Biomarkers in Disease Diagnosis and Monitoring: Insights into Clinical Applications and Mass Spectrometry-based DetectionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.